...
首页> 外文期刊>RSC Advances >One step preparation of quantum dot-embedded lipid nanovesicles by a microfluidic device
【24h】

One step preparation of quantum dot-embedded lipid nanovesicles by a microfluidic device

机译:通过微流控装置一步制备量子点包埋的脂质纳米囊泡

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Synthetic carriers that mimic "natural lipid-based vesicles" (such as microanovesicles, exosomes) have found broad applications in biomedicine for the delivery of biomolecules and drugs. Remarkable advantages of using synthetic carriers include control over the lipid composition, structure and size, together with the possibility to add tracer molecules to monitor their in situ distribution via fluorescence microscopy. Over the past few years, new methods of vesicles production have been developed and optimized, such as those based on microfluidic techniques. These innovative approaches allow us to overcome the limitations faced in conventional methods of liposome preparation, such as size distribution and polydispersity. Herein, a Microfluidic Hydrodynamic Focusing (MHF) device has been used for the production of lipid-based vesicles with different lipid combinations that resemble natural exosomes, such as phosphatidylcholines (PC), cholesterol (Chol), dicetyl phosphate (DCP) and ceramide (Cer). Thanks to a fine control on fluid manipulation, the MHF device allows preparation of vesicles with controlled size, a relevant feature in the emerging field of carrier-assisted cell-delivery. Interestingly, PC/Chol/Cer vesicles exhibit low polydispersity and high stability up to 45 days. Later, quantum dots (QDs) were successfully embedded in these vesicles through the same preparation process. The development of QD-embedded lipid nanovesicles by MHF devices has never been described previously.
机译:模仿“基于天然脂质的囊泡”的合成载体(例如微/核小囊泡,外泌体)已在生物医学中广泛应用于递送生物分子和药物。使用合成载体的显着优势包括控制脂质的组成,结构和大小,以及添加示踪分子以通过荧光显微镜监测其原位分布的可能性。在过去的几年中,已经开发和优化了新的囊泡生产方法,例如基于微流技术的囊泡生产方法。这些创新的方法使我们能够克服常规脂质体制备方法所面临的局限性,例如尺寸分布和多分散性。在本文中,微流体水力聚焦(MHF)设备已用于生产具有类似于天然外泌体的不同脂质组合的脂质基囊泡,例如磷脂酰胆碱(PC),胆固醇(Chol),磷酸二鲸蜡酯(DCP)和神经酰胺Cer)。由于可以对流体进行精确控制,因此MHF装置可以制备具有可控大小的囊泡,这是新兴的载体辅助细胞递送领域的重要特征。有趣的是,PC / Chol / Cer囊泡在长达45天的时间内显示出低多分散性和高稳定性。后来,通过相同的制备过程将量子点(QD)成功嵌入了这些囊泡中。以前从未描述过通过MHF设备开发QD包埋的脂质纳米囊泡的过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号